Without a doubt @Antipater_100, Crux is better than Proactive.
Fair point about CAI, though I would love to hear Nic's thoughts on it all now....
btw - I also held and followed MOY closely, as I do think the tenements are highly prospective. The issues seem to stem back to a poor mine plan, lack of infill drilling and.... operational issues (and too much debt). If done properly, they should not have been issues. I would not at all be averse to ALK getting the MOY assets for peanuts, but... sadly, unless it really was for peanuts, ALK funding is all tied to Tommi.
Perhaps you are right about not needing to hedge further, BUT.... there are very few examples I can think of where small caps have had $100m+ in debt and done well.... though perhaps none were as proven as ALK operationally.
As you say, if POG stays high ALK will be fine, but.... I guess I am just a bit more conservative in regards to debt.
Anyway, looking forward to the Boda study (not really for any short term SP jump, but... because it should be a good read!).
- Forums
- ASX - By Stock
- Ann: NMPP Regional Exploration Update
Without a doubt @Antipater_100, Crux is better than Proactive....
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
0.005(1.09%) |
Mkt cap ! $278.1M |
Open | High | Low | Value | Volume |
46.0¢ | 47.0¢ | 45.0¢ | $81.23K | 175.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3875 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 100508 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 41890 | 0.460 |
7 | 38596 | 0.455 |
9 | 81645 | 0.450 |
6 | 34535 | 0.445 |
11 | 27085 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 26151 | 10 |
0.470 | 99570 | 6 |
0.475 | 30480 | 7 |
0.480 | 59259 | 10 |
0.485 | 66919 | 4 |
Last trade - 10.41am 11/10/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online